Future Health Esg Corp
Future Health ESG Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Dover, Delaware.
Future Health Esg Corp (FHLT) - Net Assets
Latest net assets as of December 2023: $-211.55K USD
Based on the latest financial reports, Future Health Esg Corp (FHLT) has net assets worth $-211.55K USD as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($17.23 Million) and total liabilities ($17.44 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-211.55K |
| % of Total Assets | -1.23% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 3.32 |
Future Health Esg Corp - Net Assets Trend (2021–2023)
This chart illustrates how Future Health Esg Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Future Health Esg Corp (2021–2023)
The table below shows the annual net assets of Future Health Esg Corp from 2021 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-211.55K | -103.05% |
| 2022-12-31 | $6.94 Million | -96.41% |
| 2021-12-31 | $193.51 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Future Health Esg Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 278714500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $10.07 Million | % |
| Total Equity | $-211.55K | 100.00% |
Future Health Esg Corp Competitors by Market Cap
The table below lists competitors of Future Health Esg Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SinterCast AB
ST:SINT
|
$37.74 Million |
|
EXEL INDS S.A. A EO 25
F:8YK
|
$37.74 Million |
|
Madison Pacific Properties Inc.
TO:MPC
|
$37.75 Million |
|
Eyenovia Inc
NASDAQ:EYEN
|
$37.75 Million |
|
Haitai Confectionery and Foods Co Ltd
KO:101530
|
$37.72 Million |
|
MSM Malaysia Holdings Bhd
KLSE:5202
|
$37.72 Million |
|
Texmaco Infrastructure & Holdings Limited
NSE:TEXINFRA
|
$37.72 Million |
|
Chinyang Hold
KO:100250
|
$37.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Future Health Esg Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 6,943,142 to -211,547, a change of -7,154,689 (-103.0%).
- Net loss of 48,425 reduced equity.
- Other factors decreased equity by 7,106,264.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-48.42K | -22.89% |
| Other Changes | $-7.11 Million | -3359.19% |
| Total Change | $- | -103.05% |
Book Value vs Market Value Analysis
This analysis compares Future Health Esg Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $7.74 | $10.96 | x |
| 2022-12-31 | $0.29 | $10.96 | x |
| 2023-12-31 | $-0.03 | $10.96 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Future Health Esg Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.26%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -0.09% | 0.00% | 0.00x | 1.05x | $-19.53 Million |
| 2022 | 0.86% | 0.00% | 0.00x | 2.49x | $-634.51K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-27.27K |
Industry Comparison
This section compares Future Health Esg Corp's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Future Health Esg Corp (FHLT) | $-211.55K | -0.09% | N/A | $37.73 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |